A real-world disproportionality analysis of colchicine: data mining of the public version of FDA adverse event reporting system

Background Colchicine is widely used for gout and familial Mediterranean fever (FMF) and has cardiovascular benefits. However, it is linked to various adverse drug reactions (ADRs). This study aimed to analyze colchicine-related ADRs using FAERS data for safer clinical use.